What is King Pharmaceuticals's dividend yield?

King Pharmaceuticals (KG) reported dividend yield of 50.5% in Q4 2025.

What does dividend yield mean?

Trailing-twelve-month common dividends paid divided by market capitalization at the quarter end. The cash income return shareholders receive relative to the market price.

King Pharmaceuticals KG Dividend yield

Dividend yield at other companies

Everest GroupEG

2.5%+0.3pp

SiriusPointSPNT

0%—

KKR & Co.KKR

0.8%+0.2pp

Selective Insurance GroupSIGI

2.1%+0.6pp

Reinsurance Group of AmericaRGA

1.8%0.0pp

Tiptree Inc.TIPT

——

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Calculated from King Pharmaceuticals’s reported figures.

dividends paid/market cap=50.5%

Based on trailing twelve months.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's dividend yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's dividend yield?: King Pharmaceuticals (KG) reported dividend yield of 50.5% in Q4 2025.
What does dividend yield mean?: Trailing-twelve-month common dividends paid divided by market capitalization at the quarter end. The cash income return shareholders receive relative to the market price.